参考文献/References:
[1] Surawicz TS, Davis F, Freels S, et al. Brain tumor survival:
results from the National Cancer Data Base[J]. J Neurooncol,
1998, 40(2): 151-160.
[2] Taylor L. Diagnosis, treatment, and prognosis of glioma: five
new things [J]. Neurology, 2010, 75(18 Suppl 1): S28-S32.
[3] Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles
classify human cancers [J]. Nature, 2005, 435(7043): 834-
838.
[4] Iorio MV, Croce CM. MicroRNAs in cancer: small molecules
with a huge impact [J]. J Clin Oncol, 2009, 27(34): 5848-
5856.
[5] Bartel D. MicroRNAs: target recognition and regulatory
functions [J]. Cell, 2009, 136(2): 215-233.
[6] Bartel D. MicroRNAs: genomics, biogenesis, mechanism,
and function [J]. Cell, 2004, 116(2): 281-297.
[7] Lewis BP, Burge CB, Bartel D. Conserved seed pairing, often
flanked by adenosines, indicates that thousands of human
genes are microRNA targets [J]. Cell, 2005, 120(1): 15-20.
[8] Calin G A, Sevignani C, Dumitru CD, et al. Human micro
RNA genes are frequently located at fragile sites and geno-
mic regions involved in cancers [J]. Proc Natl Acad Sci
USA, 2004, 101(9): 2999-3004.
[9] Benetatos L, Hatzimichael E, Londin E, et al. The micro
RNAs within the DLK1-DIO3 genomic region: involvement
in disease pathogenesis [J]. Cell Mol Life Sci, 2013, 70(5):
795-814.
[10] Meng F, Wehbe-Janek H, Henson R, et al. Epigenetic regu-
lation of microRNA-370 by interleukin-6 in malignant
human cholangiocytes [J]. Oncogene, 2008, 27(3): 378-386.
[11] Zhang X, Zeng J, Zhou M, et al. The tumor suppressive role
of miRNA-370 by targeting FoxM1 in acute myeloid leuke-
mia [J]. Mol Cancer, 2012, 11: 56.
[12] Chang KW, Chu TH, Gong NR, et al. miR-370 modulates
insulin receptor substrate-1 expression and inhibits the
tumor phenotypes of oral carcinoma [J]. Oral Dis, 2013, 19
(6): 611-619.
[13] Xu WP, Yi M, Li QQ, et al. Perturbation of MicroRNA-370/
Lin-28 homolog A/nuclear factor kappa B regulatory circuit
contrbutes to the development of hepatocellular carcinoma
[J]. Hepatology, 2013, 58(6): 1977-1991.
[14] Chen XP, Chen YG, Lan JY, et al. MicroRNA-370 supp-
resses proliferation and promotes endometrioid ovarian
cancer chemosensitivity to cDDP by negatively regulating
ENG [J]. Cancer Lett, 2014, 353(2): 201-210.
[15] Zhou M, Zeng J, Wang X, et al. MiR-370 sensitizes chronic
myeloid leukemia K562 cells to homoharringtonine by
targeting Forkhead box M1 [J]. J Transl Med, 2013, 11: 265.
[16] Yungang W, Xiaoyu L, Pang T, et al. MiR-370 targeted Fox
M1 functions as a tumor suppressor in laryngeal squamous
cell carcinoma (LSCC) [J]. Biomed Pharmacother, 2014, 68
(2): 149-154.
[17] Feng Y, Wang L, Zeng J, et al. FoxM1 is overexpressed in
Helicobacter pylori-induced gastric carcinogenesis and is
negatively regulated by miR-370 [J]. Mol Cancer Res,
2013, 11(8): 834-844.
[18] Myatt SS, Lam EW. The emerging roles of forkhead box
(Fox) proteins in cancer [J]. Nat Rev Cancer, 2007, 7(11):
847-859.
[19] Liu M, Dai B, Kang SH, et al. FoxM1B is overexpressed in
human glioblastomas and critically regulates the tumorige-
nicity of glioma cells [J]. Cancer Res, 2006, 66(7): 3593-
3602.
[20] Teh MT, Wong ST, Neil GW, et al. FOXM1 is a downstream
target of Gli1 in basal cell carcinomas[J]. Cancer Res, 2002,
62(16): 4773-4780.
[21] Zhang N, Wei P, Gong A, et al. FoxM1 promotes beta-
catenin nuclear localization and controls Wnt target-gene
expression and glioma tumorigenesis [J]. Cancer Cell, 2011,
20(4): 427-442.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(04):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(04):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(04):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(04):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(04):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[10]杨佃旭 徐志明 李晓梅 王丽丽 王桂松.突入桥小脑角区胶质瘤的诊治分析(附5例报告)[J].中国临床神经外科杂志,2016,(03):171.[doi:10.13798/j.issn.1009-153X.2016.03.014]